AstraZeneca CEO Pascal Soriot Updates On Chinese Compliance Probe And Lung Cancer Drug Trial Results
Recently, Chinese authorities detained some current and former employees of AstraZeneca Plc (NASDAQ:AZN) as part of a broader investigation into alleged illegal activities in the pharmaceutical sector ...
Monday - Friday, 6:00 - 7:00 PM ET In a Tuesday interview with CNBC's Jim Cramer, AstraZeneca CEO Pascal Soriot explained why the drugmaker believes it can almost double revenue by the end of the ...
Like clockwork, AstraZeneca CEO Pascal Soriot’s pay is under fire again. Two influential advisory firms, Institutional Shareholder Services and Glass Lewis, are rallying investors to vote against AZ’s ...
1monon MSN
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success
AstraZeneca CEO Pascal Soriot said AI is helping the company develop medicines faster and make smarter decisions throughout the research process.
Hosted on MSN
Soriot plays the China card: Astra boss should be careful what he wishes for, says Alex Brummer
Whether in China or the United States, Pascal Soriot knows how to capture headlines. In Washington last year, the chief executive revealed that Britain’s biggest company AstraZeneca would be putting ...
AstraZeneca, having surpassed its long-term $45 billion revenue goal last year, has handsomely rewarded its chief executive. In fact, Pascal Soriot’s compensation package makes him the current top ...
This photo taken on Nov 7, 2025 shows the booth of AstraZeneca at the Medical Equipment and Healthcare Products Exhibition ...
Hosted on MSN
Britain losing race to make new drugs: AstraZeneca boss blasts UK for deterring investment
The boss of drug giant AstraZeneca has warned that the UK is deterring investment from the pharma industry. Chief executive Pascal Soriot said Britain should be trying to attract cash from the sector ...
SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that Pascal Soriot, CEO of AstraZeneca, and Judy Gawlik Brown, founder and CEO of Downtown Advisory, have been ...
The most expensive product in modern business is the one that never ships. Nowhere is that more true than in a pharmaceutical lab. A company can spend more than a decade and a fortune chasing a single ...
AstraZeneca (AZN) is shifting its focus to the US, calling itself an "American company" on Tuesday as it ramps up manufacturing and proposes price cuts for the US market. CEO Pascal Soriot told ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results